miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNAs (miRNAs) play diverse roles in tumorigenesis, with miR-15b-5p having contradictory functions reported across different cancers.
• The specific role of miR-15b-5p in breast cancer progression remains largely undefined.

Purpose of the Study:

• To investigate the functional role and underlying molecular mechanisms of miR-15b-5p in breast cancer.
• To determine the potential of miR-15b-5p as a prognostic biomarker and therapeutic target.

Main Methods:

• In vitro studies using breast cancer cell lines (MCF-7, MD-MBA-231) involving miRNA expression manipulation (knockdown and overexpression).
• In vivo xenograft mouse models to assess tumor growth inhibition.
• Luciferase reporter assays and rescue experiments to elucidate molecular targets and mechanisms.
• Analysis of patient data for correlation between miR-15b-5p expression and overall survival.

Main Results:

• miR-15b-5p expression was significantly upregulated in breast cancer tissues and correlated with poorer patient survival.
• miR-15b-5p knockdown suppressed breast cancer cell proliferation, migration, and invasion, while inducing apoptosis.
• Overexpression of miR-15b-5p had opposite effects, promoting cancer cell aggressiveness.
• Heparanase-2 (HPSE2) was identified as a direct target of miR-15b-5p, with inverse correlation in expression.
• miR-15b-5p knockdown inhibited tumor growth in vivo.

Conclusions:

• miR-15b-5p acts as an oncomiR in breast cancer, promoting proliferation, migration, and invasion.
• The oncogenic function of miR-15b-5p is mediated through the direct inhibition of HPSE2.
• miR-15b-5p represents a potential prognostic biomarker and a promising therapeutic target for breast cancer treatment.